CytomX Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -75.1% | -75.1% | -29.6% |
| FY2017 | -61.7% | -61.7% | -10.8% |
| FY2018 | -62.3% | -62.3% | -18.5% |
| FY2019 | -521.5% | -521.5% | -38.9% |
| FY2020 | 833.8% | 833.8% | -18.1% |
| FY2021 | 25,244.0% | 25,244.0% | -34.1% |
| FY2022 | 115.8% | 115.8% | -38.1% |
| FY2023 | 1.2% | 1.2% | -0.3% |
| FY2024 | -6,988.8% | -6,988.8% | 26.4% |
| FY2025 | -17.5% | -17.5% | -11.5% |